Alves, M. R., e Melo, N. C., Barros‐Filho, M. C., do Amaral, N. S., Silva, F. I. d. B., Baiocchi Neto, G., . . . Rocha, R. M. (2018). Downregulation of AGR2, p21, and cyclin D and alterations in p53 function were associated with tumor progression and chemotherapy resistance in epithelial ovarian carcinoma. Cancer Med.
Citação norma ChicagoAlves, Mariana Rezende, Natalia Cruz e Melo, Mateus Camargo Barros‐Filho, Nayra Soares do Amaral, Felipe Ilelis de Barros Silva, Glauco Baiocchi Neto, Fernando Augusto Soares, Louise de Brot Andrade, and Rafael Malagoli Rocha. "Downregulation of AGR2, P21, and Cyclin D and Alterations in P53 Function Were Associated With Tumor Progression and Chemotherapy Resistance in Epithelial Ovarian Carcinoma." Cancer Med 2018.
MLA CitationAlves, Mariana Rezende, et al. "Downregulation of AGR2, P21, and Cyclin D and Alterations in P53 Function Were Associated With Tumor Progression and Chemotherapy Resistance in Epithelial Ovarian Carcinoma." Cancer Med 2018.